Morpholino

MO1-mir7a

ID

ZDB-MRPHLNO-150313-1

Name

MO1-mir7a

Previous Names

None

Targets

mir7a-1 (1)
mir7a-2 (1)
mir7a-3 (1)
mir7a-4 (1)

Sequence

5' - ACAACAAAATCACTAGTCTTCCA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-mir7a

Expressed Gene	Anatomy	Figures
lmx1bb	diencephalon	Fig. S5 from Adusumilli et al., 2020
nr4a2a	diencephalon	Fig. S5 from Adusumilli et al., 2020
th	brain diencephalon	Fig. S9, Figure 6 from Adusumilli et al., 2020

Phenotype

Phenotype resulting from MO1-mir7a

No data available

Phenotype of all Fish created by or utilizing MO1-mir7a

Phenotype	Fish	Conditions	Figures
retinal outer nuclear layer cell population proliferation decreased process quality, abnormal	slc45a2^b4/b4 + MO1-mir7a	light damage: retina, constant light, high light intensity	Fig. 10 from Rajaram et al., 2014
retina regeneration process quality, abnormal	slc45a2^b4/b4 + MO1-mir7a	light damage: retina, constant light, high light intensity	Fig. 10 from Rajaram et al., 2014
retinal inner nuclear layer cell population proliferation decreased process quality, abnormal	slc45a2^b4/b4 + MO1-mir7a	light damage: retina, constant light, high light intensity	Fig. 10 from Rajaram et al., 2014
diencephalon th expression amount, ameliorated	ia4Tg + MO1-mir7a	chemical treatment by environment: XAV939	Fig. S9 from Adusumilli et al., 2020
brain GFP expression increased amount, abnormal	ia4Tg + MO1-mir7a	standard conditions	Figure 6 from Adusumilli et al., 2020
brain th expression increased amount, abnormal	ia4Tg + MO1-mir7a	standard conditions	Figure 6 from Adusumilli et al., 2020
diencephalon GFP expression increased amount, abnormal	ia4Tg + MO1-mir7a	standard conditions	Figure 2 , Figure 3 from Adusumilli et al., 2020
diencephalon Wnt signaling pathway increased occurrence, abnormal	ia4Tg + MO1-mir7a	standard conditions	Figure 3 from Adusumilli et al., 2020
brain Wnt signaling pathway increased occurrence, abnormal	ia4Tg + MO1-mir7a	standard conditions	Figure 2 from Adusumilli et al., 2020
diencephalon th expression increased amount, abnormal	ia4Tg + MO1-mir7a	chemical treatment by environment: Wnt signalling activator	Fig. S9 from Adusumilli et al., 2020
diencephalon th expression increased amount, abnormal	ia4Tg + MO1-mir7a	control	Fig. S9 from Adusumilli et al., 2020
diencephalon nr4a2a expression increased amount, abnormal	ia5Tg + MO1-mir7a	standard conditions	Fig. S5 from Adusumilli et al., 2020
diencephalon lmx1bb expression increased amount, abnormal	ia5Tg + MO1-mir7a	standard conditions	Fig. S5 from Adusumilli et al., 2020
diencephalon mCherry expression increased amount, abnormal	ia5Tg + MO1-mir7a	standard conditions	Fig. S5 from Adusumilli et al., 2020
telencephalon EGFP expression decreased amount, abnormal	vu12Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
diencephalon EGFP expression decreased amount, abnormal	vu12Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
hindbrain EGFP expression decreased amount, abnormal	vu12Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
diencephalon Wnt signaling pathway increased occurrence, abnormal	ia5Tg; nu15Tg; y1Tg + MO1-mir7a	standard conditions	Fig. S8 from Adusumilli et al., 2020
diencephalon smoothened signaling pathway decreased occurrence, abnormal	ia5Tg; nu15Tg; y1Tg + MO1-mir7a	standard conditions	Fig. S8 from Adusumilli et al., 2020
telencephalon diencephalon boundary smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
brain smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
forebrain midbrain boundary smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020
hypothalamus smoothened signaling pathway decreased occurrence, abnormal	nu15Tg; y1Tg + MO1-mir7a	standard conditions	Figure 8 from Adusumilli et al., 2020

Citations